Home › KBI Biopharma Selects Freeslate's Biologics Formulation System For Early And Late Stage Drug Development
 

Keywords :   


KBI Biopharma Selects Freeslate's Biologics Formulation System For Early And Late Stage Drug Development

2013-09-04 06:58:35| drugdiscoveryonline News Articles

Freeslate, Inc., the leading provider of high throughput research solutions, today announced that KBI Biopharma, Inc. (KBI), a leading development and contract manufacturing organization serving the biopharmaceutical industry, has purchased Freeslate’s Biologics Formulation System to help develop more robust formulations using less time and material

Tags: system development early late

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.11Tropical Storm Sara Graphics
16.11Tropical Storm Sara Forecast Discussion Number 12
16.11Tropical Storm Sara Wind Speed Probabilities Number 12
16.11Tropical Storm Sara Forecast Advisory Number 12
16.11Tropical Storm Sara Public Advisory Number 12
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11SRAM Level T
16.11 alone at home t XL
More »